TQ Evening Briefing

More Fed officials wanted a hike in October than the vote showed. Treasuries rallied anyway, while oil and gold fell hard.

The Setup

The Fed Leaned Tighter. The Inputs Got Cheaper.

The S&P 500 slipped 0.2%, its fifth straight loss. The Dow fell 1.1% as health insurers sank, while the Nasdaq rose 0.4%. Nvidia (NVDA) gave back its post-earnings gain and closed down 2.9%.

The Fed's October minutes showed broader support for higher rates than the 10-2 vote suggested. The vast majority of officials saw inflation risks tilted higher, citing energy prices.

Bonds shrugged it off. The 10-year yield slipped to 5.07% from 5.10% on Tuesday.

The energy prices the minutes worried about fell instead, with U.S. crude down more than 4%. Gold fell about 3.5% on a day yields eased, and bitcoin lost nearly 4% to about $62,400.

Retailers bucked the selling. TJX (TJX) jumped 8.0% after raising its full-year outlook.

TQ Trade Implication

Policymakers are leaning toward more hikes just as fuel gets cheaper. Falling energy prices work against the pressure the minutes cited, and bond buyers sided with the prices over the words. That makes the long end a bet that energy keeps easing. If yields fall again on a day crude rises, bonds are pricing a slowdown instead of cheaper inputs.

PREMIER FEATURE

The 7 Stocks Built to Outlast the Market

Some stocks are built for a quarter… others for a lifetime.

Our 7 Stocks to Buy and Hold Forever report reveals companies with the strength to deliver year after year - through recessions, rate hikes, and even the next crash.

One is a tech leader with a 15% payout ratio - leaving decades of room for dividend growth.

Another is a utility that’s paid every quarter for 96 years straight.

And that’s not all - we’ve included 5 more companies that treat payouts as high priority.

These are the stocks that anchor portfolios and keep paying.

This is your chance to see all 7 names and tickers - from a consumer staples powerhouse with 20 years of outperformance to a healthcare leader with 61 years of payout hikes.

The report is free for a limited time - go here to get it now.

Theme One

The Bigger-Hike Idea Predates Waller's Pitch. Traders Added Three Cents.

The minutes said "some participants" favored a quarter-point hike in October. Only Governor Lisa Cook and Cleveland Fed President Beth Hammack dissented for one. A couple said December could call for more than a quarter point if inflation data were unfavorable. The meeting predated October's consumer price report.

Governor Christopher Waller told CNBC the Fed has two choices. It can raise rates half a point in December, or pair a quarter point with a clear signal of a January hike. The Fed may need to "shock people," he said.

Kalshi's contract on a December hike of more than 25 basis points had been sliding since Sunday, when it fell to 9 cents from 11. It sat at 5 by Wednesday. It rose to 7 after the interview, hit 9 on the minutes and ended near 8. The quarter-point contract slipped to 90 to 91 cents from 92.

TQ Edge Setup

The jumbo-hike bet moved from long shot to a slightly shorter long shot. The minutes show the bigger-hike idea had backers before October's inflation data arrived, so Waller is not arguing alone. That leaves the size of December's move open even with a quarter point close to settled. If the contract slides back to 5 cents before the meeting, traders are treating Waller as an outlier.

Theme Two

The Rule Didn't Change Overnight. The Losses Got Bigger.

UnitedHealth (UNH) fell 10.2% and Humana (HUM) 13.0%. On Tuesday they lost 5.4% and 3.9%. Both slides followed a proposed Medicare rule released Monday, and its text did not change between the two sessions.

The rule would let Medicare apply audit findings from a sample to a whole Medicare Advantage plan, starting with 2018 payments. It would apply no fee-for-service adjuster, an offset insurers argue the law requires. The agency estimates it would recover about $9 billion per payment year on average.

UnitedHealth and Humana run the two largest Medicare Advantage books. Neither has put a number on its exposure.

A court struck down a 2023 version in 2025 on procedural grounds, and the government's appeal is still pending. This time the policy sits in the proposal itself. Comments close Jan. 19.

TQ Execution Bias

The market is pricing a clawback that no insurer has sized and no court has approved. The 2025 loss turned on process, which this proposal fixes, so investors' legal cushion is thinner. That tilts against the biggest Medicare Advantage players until a number appears. If a court rejects the method on its merits, the second day of selling looks overdone.

FROM OUR PARTNERS

The REAL Reason Trump Is Invading Iran

For a moment…

Forget about Trump’s ties to Israel.

Forget about reports of Iran’s nuclear program.

Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.

Click here to find out what it is.

If you have even a single dollar invested in the U.S. stock market, this is going to directly impact you.

Discover the reason here.

Theme Three

Strip Out the Tariff Refunds and the Winners Line Up.

All three big retailers that reported Wednesday booked tariff refunds.

Target (TGT) earned $2.65 a share, including 50 cents from refunds. Without them, profit still beat forecasts near $2.07. Comparable sales rose 5.6% on 5.0% more traffic. The stock rose 4.0%.

TJX's adjusted profit leaves its refunds out and matched forecasts. Comparable sales grew 4%, above its own 2% to 3% plan.

Lowe's (LOW) reported adjusted profit of $3.10 a share, including 34 cents of refunds. Without them it was about $2.76, below the roughly $2.88 analysts expected. Lowe's also trimmed its margin outlook, and the shares rose 1.1%.

TQ Execution Bias

The biggest gains went to the cleaner results. Refunds do not recur, so a beat that depends on them says little about next year. That tilts toward retailers whose results held up on their own, like Target and TJX. If refund-padded beats start drawing the same rallies as clean ones, the market has stopped checking.

Quick Themes
  • Palo Alto cleared a bar its own rally raised. Palo Alto Networks (PANW) rose 9.9% into its report. Revenue then came in at $3.44 billion, up 39% and above forecasts. It raised its full-year sales outlook and agreed to buy AI startup Applied Compute for $4.5 billion. The shares climbed further after hours.
  • Anthropic cleared its range. Anthropic priced its IPO at $83 a share, above the $70 to $78 range, according to people familiar with the deal. The shares are set to start trading Thursday on Nasdaq as ANT. Buyers paid up for AI exposure on a day Nvidia fell.
  • A German court priced a criminal case in bitcoin. Last week a Leipzig judge offered to drop the case against the alleged operator of the defunct piracy site Movie2k, prosecutors confirmed. He would hand over 40,000 more bitcoin, about $2.5 billion, and pay €38 million to potential victims. Saxony sold nearly 50,000 bitcoin from him in 2024, so a deal would hand another big block to a proven seller.
PARTNER SPOTLIGHT

The $3 Trillion Crisis That Almost NOBODY Is Talking About

According to Wall Street legend Dr. Martin D. Weiss, there’s a $3 trillion financial crisis happening right now.

And almost nobody but him is warning people.

In fact, according to WSJ, this $3 trillion market “is under growing strain, despite industry’s upbeat tone.”

Weiss says the biggest danger is NOT just another stock market crash.

The biggest danger is NOT only a major bank failure.

Rather, it’s a chain reaction of crashes and failures across the globe.

>Go here now to see his shocking warning.

11780 US Highway 1,

Palm Beach Gardens, FL 33408-3080

Would you like to edit your e-mail notification preferences or unsubscribe from our mailing list?

Copyright © 2026 Weiss Ratings. All rights reserved.

The Close

Bonds Bet on Cheaper Inputs. Shoppers Kept Spending.

The Fed's words got tougher and its inflation inputs got cheaper, and bonds sided with the inputs. Shoppers did not pull back. Target's traffic grew and TJX beat its own plan, the kind of demand the hawks want to cool.

The bond rally now leans on crude staying down. If oil steadies and the 10-year still holds below Tuesday's 5.10%, bond buyers are betting inflation cools faster than the Fed expects. If it climbs back above that level, Wednesday's rally was a pause.

AI Found the Target. AI Designed the Drug. Now It's in Phase III.

For years, AI drug discovery had a problem. Plenty of models. Very few medicines.
That's changing. One company says AI identified the biological target and then designed the molecule to hit it. In September, the first patient in its Phase III trial was dosed.
It isn't alone. A second AI-engineered medicine is in Phase III, and Big Pharma is now paying for the technology.
We profiled the 5 companies pushing AI into real drug development in a new FREE Special Report: AI Moves Into the Biotech Lab.
We'll text it straight to your phone.

Get the Free Report by Text →